Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharmadrug Inc (LMLLF)

Pharmadrug Inc (LMLLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LMLLF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0210 +19.52%
on 04/22/24
0.0310 -19.03%
on 04/05/24
-0.0070 (-21.81%)
since 03/26/24
3-Month
0.0210 +19.52%
on 04/22/24
0.0575 -56.35%
on 03/13/24
-0.0074 (-22.77%)
since 01/26/24
52-Week
0.0106 +136.79%
on 10/25/23
0.0658 -61.85%
on 05/08/23
-0.0253 (-50.20%)
since 04/26/23

Most Recent Stories

More News
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine

Victoria's Chiral Labs to lead development of novel cocaine manufacturing processToronto, Ontario--(Newsfile Corp. - April 16, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine

Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman

Toronto, Ontario--(Newsfile Corp. - February 27, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies

Company to pursue regulatory filing for Phase I/II clinical studyToronto, Ontario--(Newsfile Corp. - February 14, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"),...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), today announced that it has entered into (i) a marketing and distribution...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - February 8, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), is pleased to announce the closing of its previously announced non-brokered...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug Announces Share Consolidation and Change to Chief Financial Officer

Toronto, Ontario--(Newsfile Corp. - October 20, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that it will be proceeding with the consolidation of...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug Announces Amendment to Shareholder Meeting Matter

Toronto, Ontario--(Newsfile Corp. - September 19, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that, further to its press release dated September...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug Provides Development Update of Cepharanthine (PD-001) for Cancer and Infectious Disease

Toronto, Ontario--(Newsfile Corp. - September 14, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is pleased to provide an update on the development activities of the...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)
PharmaDrug Announces Appointment of CEO and Changes to the Board of Directors

Toronto, Ontario--(Newsfile Corp. - September 6, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today the appointment of Robert J. Steen as Chief Executive...

LMLLF : 0.0251 (-0.40%)
PHRX.CN : 0.0300 (-14.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0268
2nd Resistance Point 0.0260
1st Resistance Point 0.0255
Last Price 0.0251
1st Support Level 0.0242
2nd Support Level 0.0234
3rd Support Level 0.0229

See More

52-Week High 0.0658
Fibonacci 61.8% 0.0447
Fibonacci 50% 0.0382
Fibonacci 38.2% 0.0317
Last Price 0.0251
52-Week Low 0.0106

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar